Combinatorial Chemistry definition

Combinatorial Chemistry means techniques, methodologies, processes, synthetic routes or instrumentation useful for the simultaneous, parallel or rapid serial: (i) synthesis, (ii) processing, (iii) analysis, or (iv) characterization of more than ten (10) compounds, compositions or mixtures in quantities of less than ten (10) grams.
Combinatorial Chemistry means the synthesis of one or more compounds as part of a process to create compounds or resynthesize known compounds, where such compounds are to be used in clinical applications or in the discovery, development, testing or optimization of molecules, materials, or compounds, or mixtures thereof.
Combinatorial Chemistry means techniques, methodologies, processes, synthetic routes or instrumentation useful for the simultaneous, parallel or rapid serial: (i) synthesis, (ii) processing, (iii) analysis, or (iv) characterization of more than * compounds, compositions or mixtures in quantities of less than * for purposes of research and development experimentation (i.e., not production processes or the process control, the quality control or the monitoring of such operations.), but shall not refer to particular compositions of matter, materials, compounds or formulations (e.g.*, etc.) or processes to make or use such particular compositions of matter, materials, compounds or formulations.

Examples of Combinatorial Chemistry in a sentence

  • Symyx shall have the sole right, in its discretion and at its sole expense, to prepare, file, prosecute and maintain patent applications and patents relating to Joint Inventions owned by TDCC and Symyx which claim Combinatorial Chemistry Technology and to conduct any interferences, re-examinations, reissues, oppositions or requests for patent term extension or governmental equivalents thereto.

  • Notwithstanding the licenses and rights granted by Symyx in this Article 4, Symyx shall retain the right to make, have made, and use any Library Compounds or Agreement Compounds, and use or practice any processes or methods developed by or on behalf of Symyx in the course of performing the Research Program, for its own internal research to develop, improve and validate its tools and Combinatorial Chemistry Technology.

  • Symyx shall use reasonable efforts to ensure that the most efficient and effective Combinatorial Chemistry Technology reasonably available to Symyx are made available for conducting the Research Program.

  • Subject to the license to Combinatorial Chemistry Technology in Section 4.6, TDCC and Symyx shall each retain all rights outside the scope of the Fields in and to inventions and discoveries invented or made solely by such party in the course of the Research Program.

  • Combinatorial Chemistry & High Throughput Screening, 8, 5-14 (2005).[26ter] Pattanaik, P., et al., Prospectives in drug design against malaria, Current Topics in Medicinal Chemistry, 2, 483-505 (2002).[27] Lander, E.S., et al., Initial sequencing and analysis of the human genome, Nature 409, 860–921 (2001).[28] Venter, J.C., et al., The sequence of the human genome, Science 291, 1304–1351 (2001).[29] Holt, R., et al., The genome sequence of the malaria mosquito Anopheles gambiae.

  • Symyx shall retain sole ownership of, and all rights to, Combinatorial Chemistry Technology, and any inventions or discoveries conceived or reduced to practice or otherwise developed by Symyx and/or Bayer relating to Combinatorial Chemistry Technology, developed in connection with the conduct of the Research Program.

  • Symyx and Bayer shall promptly report to the RFC of each Field any inventions relating to Lead Compounds or Program Technology or Combinatorial Chemistry Technology made in the course of performing the Research Program.

  • TDCC agrees to grant, and hereby grants, to Symyx an irrevocable, royalty-free non-exclusive license, with the right to grant and authorize sublicenses, under TDCC’s interest in Combinatorial Chemistry Technology made or invented solely by TDCC in the course of the Research Program, to conduct activities using Combinatorial Chemistry.

  • In addition to the other terms and conditions herein, the following terms and conditions shall apply with respect to Combinatorial Chemistry ("CC") Technology.

  • Such extensions may include funding for the transfer of Licensed Technology to the Combinatorial Chemistry Field, the In-vitro Diagnostic Field or any other Option Field for which Orchid has an exclusive license hereunder.


More Definitions of Combinatorial Chemistry

Combinatorial Chemistry means techniques, methodologies, instrumentation, or software directed to the simultaneous, parallel, or rapid serial Laboratory Scale: (a) synthesis, (b) processing, (c) analysis, or (d) characterization of more than * Materials. “Laboratory Scale” as used in this Agreement shall mean activities not involving production of greater than * per day of such Materials.
Combinatorial Chemistry means techniques, methodologies, instrumentation, or software directed to the simultaneous, parallel, or rapid serial Laboratory Scale: (a) synthesis, (b) processing, (c) analysis, or (d) characterization of [ * ] Materials. “Laboratory Scale” as used in this Agreement means activities not involving production of greater than [ * ] of such Materials.

Related to Combinatorial Chemistry

  • Collaboration has the meaning set forth in Section 2.1.

  • Development Program means the implementation of the development plan.

  • scientific research means any activity in the field of natural or applied science for the extension of knowledge;

  • Biomarker means a characteristic that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes, or pharmacologic responses to a specific therapeutic intervention. Biomarkers include, but are not limited to, gene mutations or protein expression.

  • Program Technology means Program Know-How and Program Patents.

  • Development Plan has the meaning set forth in Section 3.2.

  • ISIS means the department’s individualized services information system.

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.

  • Research Plan shall have the meaning set forth in Section 2.1.

  • Program Plan means the tobacco settlement program plan dated February 14, 2001, including exhibits to the program plan, submitted by the authority to the legislative council and the executive council, to provide the state with a secure and stable source of funding for the purposes designated by section 12E.3A and other provisions of this chapter.

  • Collaboration Know-How means all Know-How conceived, discovered, developed or otherwise made by or on behalf of a particular Party or any of its Affiliates or permitted subcontractors of any of the foregoing (solely or jointly by or on behalf of a particular Party or any of its Affiliates or permitted subcontractors of any of the foregoing) in the course of [***].

  • Collaboration Patents means any and all Patents that claim or cover any of the Collaboration Know-How.

  • Development Application means the development application identified in Item 5 of Schedule 1 and includes all plans, reports models, photomontages, material boards (as amended supplemented) submitted to the consent authority before the determination of that Development Application.

  • Collaboration Technology means all Collaboration Patents and Collaboration Know-How.

  • Development Plans means a coherent set of operations defined and financed exclusively by the OCTs in the framework of their own policies and strategies of development, and those agreed upon between an OCT and the Member State to which it is linked;

  • Research Program has the meaning set forth in Section 3.1.

  • CMC means Comprehensive maintenance Contract (labour, spare and preventive maintenance)

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Commercialization Plan has the meaning set forth in Section 6.2.

  • Collaboration Target means the Initial Collaboration Targets set forth on Exhibit F and any Additional Target or Substitute Target that is selected in accordance with Section 3.3 of this Agreement.

  • Bioassay means the determination of kinds, quantities or concentrations and, in some cases, the locations of radioactive material in the human body, whether by direct measurement, in vivo counting, or by analysis and evaluation of materials excreted or removed from the human body. For purposes of these rules, “radiobioassay” is an equivalent term.

  • Merck has the meaning set forth in the preamble.

  • genocide means any of the following acts committed with intent to destroy, in whole or in part, a national, ethnical, racial or religious group, as such:

  • Commercialization or “Commercialize” means any and all activities undertaken at any time for a particular Licensed Product and that relate to the manufacturing, marketing, promoting, distributing, importing or exporting for sale, offering for sale, and selling of the Licensed Product, and interacting with Regulatory Authorities regarding the foregoing.

  • BMS means the Company, all related companies, affiliates, subsidiaries, parents, successors, assigns and all organizations acquired by the foregoing.

  • Library means an organized collection of resources made accessible to the public for reference or borrowing supported with money derived from taxation.